Rxsight Inc (RXST)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $223.06M
Last updated: Nov 17, 2026 at 4:10 PM ET
Rxsight Inc (RXST) Stock Chart
Rxsight (RXST) has a latest price of $4.83 on Nov 17, 2026, 63.5% below its 52-week high of $13.22. Its price fell 50.4% over the past 12 months. The month-end price fell 59.3% over the 5 years through Oct 2026, a compound annual decline of 16.5%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $60.17 in Jun 2024 and its lowest $4.82 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RXST with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RXST.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 21.6%, and over 6 months it fell 18.8%. The month-end price fell 78.0% over the 3 years through Oct 2026, a compound annual decline of 39.6%.
| Period | Change |
|---|---|
| 1 month | +3.0% |
| 3 months | -21.6% |
| 6 months | -18.8% |
| 12 months | -50.4% |
| 12 months, with dividends | -50.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -78.0% | -39.6% |
| 5 years | -59.3% | -16.5% |
Price by Year
Its best calendar year was 2023, when the price rose 218.2%, and its weakest was 2025, when it fell 69.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.87 | -53.3% |
| 2025 | $10.42 | -69.7% |
| 2024 | $34.38 | -14.7% |
| 2023 | $40.32 | +218.2% |
| 2022 | $12.67 | +12.6% |
Trading Range
The price is 3.1% below its 50-day average of $4.99 and 20.8% below its 200-day average of $6.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.83 | |
| 52-week high | $13.22 | -63.5% |
| 52-week low | $4.11 | +17.5% |
| 50-day average | $4.99 | -3.1% |
| 200-day average | $6.10 | -20.8% |
Price Risk
Over 3 years, its largest fall from a peak was 93.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -65.5% |
| Largest fall, 3 years | -93.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RXST
What is RXST's 1-year price change?
Rxsight's price fell 50.4% over the past 12 months. With dividends included, the 12-month total return was -50.4%.
What is RXST's 5-year price change?
Rxsight's month-end price fell 59.3% over the 5 years through Oct 2026, a compound annual decline of 16.5%. These figures leave out dividends.
What is RXST's 52-week high and low?
Rxsight's 52-week high is $13.22 and its 52-week low is $4.11. Its latest price of $4.83 on Nov 17, 2026 is 63.5% below the high.
What is RXST's beta?
Rxsight's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 65.5%.
Is the RXST chart free?
Yes. Advanced Charting for RXST is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RXST pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors